Ironwood Pharmaceuticals (IRWD) PT Raised to $10.50 at TD Cowen
Tweet
Share
E-mailGet Alerts IRWD Hot Sheet
Price: $4.14 -5.05%
Rating Summary:
11 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
11 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
TD Cowen analyst Borisk Peaker raised the price target on Ironwood Pharmaceuticals (NASDAQ: IRWD) to $10.50 (from $9.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Rubrik Inc (RBRK) PT Raised to $120 at Oppenheimer; Sees Another 'Beat and Raise'
- Myriad Genetics (MYGN) PT Lowered to $2.50 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
